Home / Generics
Generics
News
Teva launches first Truvada and Atripla generics and two digital inhalers
posted 20/11/2020
On 2 October 2020, Teva Pharmaceuticals announced the launch of the first US Food and Drug Administration (FDA) approved gene... 
EMA recommends approval of Lenalidomide Mylan
posted 13/11/2020
The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 15 October 2020 that... 
COVID-19 vaccine progress and FDA approvals for Zydus Cadila
posted 13/11/2020
India-based generics company, Zydus Cadila, has had many advancements with product development and approval between August an... 
FDA approves Glenmark and Cipla generics
posted 30/10/2020
Glenmark Pharmaceuticals and Cipla Limited have announced that they have received US food and Drug Administration (FDA) appro... 
Sun Pharma launches Ilumya in Japan and favipiravir in India
posted 19/10/2020
Sun Pharmaceutical Industries Inc (Sun Pharma) announced that their innovative biopharmaceutical product, Ilumya (tildrakizum... |
Research
Perspectives of prescribing practices in public health facilities in Eswatini
posted 20/01/2021
Rational medicines use (RMU) is the prescribing/dispensing of good quality medicines to meet individual patient’s clinical ne...
Familiarity with substitution of prescription generics increases positive attitudes toward OTC generics
posted 11/12/2020
Introduction of measures to stimulate increased sale of generics swept over the Nordic countries in the 2000s. In Sweden, in... 
Cost savings after switching to generic tacrolimus
posted 04/12/2020
The use of narrow therapeutic index generic immunosuppressant in solid organ transplantation is controversial. This is becaus... 
Equivalent adherence with brand and generic osteoporosis treatments
posted 27/11/2020
Osteoporosis patients are just as likely to adhere to a generic bisphosphonate treatment as they are to a brand-name product,... 
Pharmacokinetics and generic drug switching: a regulators view
posted 18/11/2020
Researchers from the Netherlands share their view on the pharmacokinetic aspects of generic drug switching, from a regulatory... |
General
Generics applications under review by EMA – January 2021
posted 22/01/2021
Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo... 
A European pharmaceutical strategy promoting generics and biosimilars
posted 08/01/2021
The European Commission has adopted a new Pharmaceutical Strategy for Europe [1], as of 25 November 2020. 
Pfizer sues Aurobindo and Dr Reddy’s over Ibrance (palbociclib) generics
posted 27/11/2020
US-based pharmaceutical company, Pfizer, has filed petitions in US courts against Aurobindo Pharma and Dr Reddy’s Laboratories. 
China prioritizes drug innovation while increasing access to drugs approved abroad
posted 26/11/2020
China's pharmaceutical industry is undergoing a transformation towards high-quality and innovation-focused development, which...
Brazil sees a COVID vaccine setback but treatment advancement
posted 06/11/2020
In Brazil’s quest to tackle the COVID-19 pandemic, there has been a volunteer death in a potential vaccine trial, but a poten... |
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Generics News Research General
- Generics applications under review by EMA – Jan...Generics/General | Posted 22/01/2021
- Perspectives of prescribing practices in public...Generics/Research | Posted 15/01/2021
- A European pharmaceutical strategy promoting ge...Generics/General | Posted 08/01/2021
- Familiarity with substitution of prescription g...Generics/Research | Posted 11/12/2020
Biosimilars News Research General
- Samsung biosimilars: denosumab clinical trials...Biosimilars/General | Posted 22/01/2021
- Biosimilars of filgrastimBiosimilars/General | Posted 20/03/2015
- EMA recommends approval of adalimumab and insul...Biosimilars/News | Posted 22/01/2021
- Biosimilars and lack of resourcesBiosimilars/Research | Posted 22/01/2021